Trial Profile
Effects of Fixed-dose Enalapril/Lercanidipine on Biomarkers of Cardiovascular Risk in Hypertensive Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Dec 2014
Price :
$35
*
At a glance
- Drugs Lercanidipine/enalapril (Primary) ; Enalapril; Lercanidipine
- Indications Essential hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 02 Dec 2014 New trial record